Isolated left main coronary artery stenosis: long term follow up in 106 patients after surgery

d'Allonnes, F Revault

doi:10.1136/heart.87.6.544

Cited by 50 publications

(27 citation statements)

References 16 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…1 Some retrospective studies evaluating surgical treatment for this disease reported an in-hospital mortality rate varying from 1.7% to 7.0% and a 1-year mortality rate of 6% to 14%. [17][18][19][20] Conversely, the treatment of LMCA stenosis by PCI is still debated. In these patients, PCI has thus far been performed only in exceptional cases, albeit with positive results.…”

Section: Discussionmentioning

confidence: 99%

Percutaneous Treatment With Drug-Eluting Stent Implantation Versus Bypass Surgery for Unprotected Left Main Stenosis

et al. 2006

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 99%

Percutaneous Treatment With Drug-Eluting Stent Implantation Versus Bypass Surgery for Unprotected Left Main Stenosis

et al. 2006

View full text Add to dashboard Cite

show abstract

“…Ostial, n (%) 77 (52) Shaft, n (%) 41 (28) Ostial and shaft, n (%) 29 (20) No. of vessels treated 1.53Ϯ0.7…”

Section: Table 2 Lesion and Procedural Characteristics Of The Study mentioning

confidence: 99%

Favorable Long-Term Outcome After Drug-Eluting Stent Implantation in Nonbifurcation Lesions That Involve Unprotected Left Main Coronary Artery

et al. 2007

View full text Add to dashboard Cite

Background-The presence of a lumen narrowing at the ostium and the body of an unprotected left main coronary artery but does not require bifurcation treatment is a class I indication of surgical revascularization. Methods and Results-A total of 147 consecutive patients who had a stenosis in the ostium and/or the midshaft of an unprotected left main coronary artery (treatment of the bifurcation not required) and were electively treated with percutaneous coronary intervention and sirolimus-eluting stents (nϭ107) or paclitaxel-eluting stents (nϭ40) in 5 centres were included in this registry. In 72 patients (almost 50%), intravascular ultrasound guidance was performed. Procedural success was achieved in 99% of the patients; in 1 patient with stenosis in the left main coronary artery ostium, a Ͼ30% residual stenosis persisted at the end of the procedure, and the patient was referred for coronary artery bypass graft surgery. During hospitalization, no patients experienced a Q-wave myocardial infarction or died. One patient died 19 days after the procedure because of pulmonary infection. At long-term clinical follow-up (886Ϯ308 days), 5 patients had died; 7 patients had target vessel revascularization (5 repeat percutaneous coronary interventions and 2 coronary artery bypass graft surgeries), and of these only 1 patient had a target lesion revascularization. Angiographic follow-up was performed in 106 patients (72%) with a late loss of Ϫ0.01 mm. Restenosis in the left main trunk occurred only in 1 patient (0.9%). Conclusions-Percutaneous coronary intervention with sirolimus-eluting stents or paclitaxel-eluting stents implantation in nonbifurcation left main coronary artery lesions appears safe with a long-term major adverse clinical event rate of 7.4% and a restenosis rate of 0.9%. (Circulation. 2007;116:158-162.)

show abstract

“…Lesions in the ULM are considered a standard indication for surgical revascularization. 1,2 Some studies have demonstrated that stenting of the ULM is feasible and appears to be a promising strategy in selected patients. [3][4][5][6][7][8] Recently, use of a drug-eluting stent (DES), either a sirolimus-eluting stent (SES; Cypher, Cordis, Johnson and Johnson Co) or a paclitaxel-eluting stent (PES; Taxus, Boston Scientific), has been associated with a low restenosis rate.…”

mentioning

confidence: 99%

Early and Mid-Term Results of Drug-Eluting Stent Implantation in Unprotected Left Main

et al. 2005

View full text Add to dashboard Cite

show abstract

Isolated left main coronary artery stenosis: long term follow up in 106 patients after surgery

Cited by 50 publications

References 16 publications

Percutaneous Treatment With Drug-Eluting Stent Implantation Versus Bypass Surgery for Unprotected Left Main Stenosis

Percutaneous Treatment With Drug-Eluting Stent Implantation Versus Bypass Surgery for Unprotected Left Main Stenosis

Favorable Long-Term Outcome After Drug-Eluting Stent Implantation in Nonbifurcation Lesions That Involve Unprotected Left Main Coronary Artery

Early and Mid-Term Results of Drug-Eluting Stent Implantation in Unprotected Left Main

Contact Info

Product

Resources

About